Conversely, after 2 months of anti-BRAF/MEK therapy, macroscopic hematuria ensued, only to further reveal an apparently “de novo” bladder tumor, ~2.8 cm in diameter, localized on the right lateral wall. The gene discussed is BRAF; the disease is urinary bladder neoplasm.